Page last updated: 2024-09-04

rhodioloside and Arrhythmias, Cardiac

rhodioloside has been researched along with Arrhythmias, Cardiac in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chang, SL; Chen, SA; Chung, FP; Higa, S; Hsiao, YW; Hu, YF; Huang, YT; Lin, SF; Lin, YJ; Liu, SH; Lo, LW; Tsai, YN	1
Briedis, V; Kucinskaite, A; Savickas, A	1

Reviews

1 review(s) available for rhodioloside and Arrhythmias, Cardiac

Article	Year
[Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine]. Medicina (Kaunas, Lithuania), 2004, Volume: 40, Issue:7 Topics: Adaptation, Physiological; Adult; Animals; Anti-Arrhythmia Agents; Antidepressive Agents; Antineoplastic Agents; Antioxidants; Arrhythmias, Cardiac; Central Nervous System; Clinical Trials as Topic; Depression; Glucosides; Humans; Lymnaea; Medicine, Traditional; Mental Fatigue; Neoplasms; Phenols; Phenylethyl Alcohol; Phytotherapy; Plant Extracts; Plant Preparations; Rats; Resins, Plant; Rhodiola	2004

Article

Year

[Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine].

Medicina (Kaunas, Lithuania), 2004, Volume: 40, Issue:7

Topics: Adaptation, Physiological; Adult; Animals; Anti-Arrhythmia Agents; Antidepressive Agents; Antineoplastic Agents; Antioxidants; Arrhythmias, Cardiac; Central Nervous System; Clinical Trials as Topic; Depression; Glucosides; Humans; Lymnaea; Medicine, Traditional; Mental Fatigue; Neoplasms; Phenols; Phenylethyl Alcohol; Phytotherapy; Plant Extracts; Plant Preparations; Rats; Resins, Plant; Rhodiola

2004

Other Studies

1 other study(ies) available for rhodioloside and Arrhythmias, Cardiac

Article	Year
Rhodiola crenulata reduces ventricular arrhythmia through mitigating the activation of IL-17 and inhibiting the MAPK signaling pathway. Cardiovascular drugs and therapy, 2021, Volume: 35, Issue:5 Topics: Animals; Anti-Inflammatory Agents; Arrhythmias, Cardiac; CD4 Lymphocyte Count; Chemokine CCL20; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Electrocardiography; Glucosides; Inflammation Mediators; Interleukin-17; MAP Kinase Signaling System; NLR Family, Pyrin Domain-Containing 3 Protein; Phenols; Rabbits; Rhodiola; RNA, Messenger; Signal Transduction	2021

Article

Year

Rhodiola crenulata reduces ventricular arrhythmia through mitigating the activation of IL-17 and inhibiting the MAPK signaling pathway.

Cardiovascular drugs and therapy, 2021, Volume: 35, Issue:5

Topics: Animals; Anti-Inflammatory Agents; Arrhythmias, Cardiac; CD4 Lymphocyte Count; Chemokine CCL20; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Electrocardiography; Glucosides; Inflammation Mediators; Interleukin-17; MAP Kinase Signaling System; NLR Family, Pyrin Domain-Containing 3 Protein; Phenols; Rabbits; Rhodiola; RNA, Messenger; Signal Transduction

2021